Journal of Hepatology
Volume 52, Issue 5 , Pages 712-717 , May 2010

Genetic associations in Italian primary sclerosing cholangitis: Heterogeneity across Europe defines a critical role for HLA-C

  • Johannes R. Hov

      Affiliations

    • Department of Medicine and Research Institute for Internal Medicine, Rikshospitalet, Oslo University Hospital, Oslo, Norway
    • Institute of Immunology, Rikshospitalet, Oslo University Hospital, Oslo, Norway
    • Faculty Division Rikshospitalet, Faculty of Medicine, University of Oslo, Oslo, Norway
    • These authors contributed equally to this work.
    • ,
  • Ana Lleo

      Affiliations

    • Department of Translational Medicine, Università degli Studi di Milano, Rozzano, Italy
    • Division of Internal Medicine and Hepatobiliary Immunopathology Unit, IRCCS-Istituto Clinico Humanitas, Rozzano, Italy
    • These authors contributed equally to this work.
    • ,
  • Carlo Selmi

      Affiliations

    • Department of Translational Medicine, Università degli Studi di Milano, Rozzano, Italy
    • Division of Internal Medicine and Hepatobiliary Immunopathology Unit, IRCCS-Istituto Clinico Humanitas, Rozzano, Italy
    • ,
  • Bente Woldseth

      Affiliations

    • Department of Medicine and Research Institute for Internal Medicine, Rikshospitalet, Oslo University Hospital, Oslo, Norway
    • Institute of Immunology, Rikshospitalet, Oslo University Hospital, Oslo, Norway
    • ,
  • Luca Fabris

      Affiliations

    • Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy
    • Center for Liver Research (CeLiveR), Ospedali Riuniti di Bergamo, Bergamo, Italy
    • ,
  • Mario Strazzabosco

      Affiliations

    • Department of Clinical Medicine and Prevention, University of Milan-Bicocca, Monza, Italy
    • Liver Center, Yale University, New Haven, USA
    • ,
  • Tom H. Karlsen

      Affiliations

    • Department of Medicine and Research Institute for Internal Medicine, Rikshospitalet, Oslo University Hospital, Oslo, Norway
    • Faculty Division Rikshospitalet, Faculty of Medicine, University of Oslo, Oslo, Norway
    • Corresponding Author InformationCorresponding author. Address: Norwegian PSC Research Center, Department of Medicine, Rikshospitalet, Oslo University Hospital, Oslo N-0027, Norway. Tel.: +47 23 07 2469; fax: +47 23 07 3510.
    • ,
  • Pietro Invernizzi

      Affiliations

    • Division of Internal Medicine and Hepatobiliary Immunopathology Unit, IRCCS-Istituto Clinico Humanitas, Rozzano, Italy

Received 21 August 2009 ,Revised 15 October 2009 ,Accepted 1 November 2009.

References 

  1. O’Mahony CA, Vierling JM. Etiopathogenesis of primary sclerosing cholangitis. Semin Liver Dis. 2006;26:3–21
  2. Bergquist A, Montgomery SM, Bahmanyar S, Olsson R, Danielsson A, Lindgren S, et al. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2008;6:939–943
  3. Karlsen TH, Schrumpf E, Boberg KM. Genetic epidemiology of primary sclerosing cholangitis. World J Gastroenterol. 2007;13:5421–5431
  4. Schrumpf E, Fausa O, Forre O, Dobloug JH, Ritland S, Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol. 1982;17:187–191
  5. Klein J, Sato A. The HLA system. First of two parts. N Engl J Med. 2000;343:702–709
  6. Moloney MM, Thomson LJ, Strettell MJ, Williams R, Donaldson PT. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis. Hepatology. 1998;28:660–662
  7. Donaldson PT, Norris S. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity. 2002;35:555–564
  8. Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA, et al. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens. 2007;69:161–169
  9. Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens. 1999;53:459–469
  10. Leidenius MH, Koskimies SA, Kellokumpu IH, Hockerstedt KA. HLA antigens in ulcerative colitis and primary sclerosing cholangitis. APMIS. 1995;103:519–524
  11. Neri TM, Cavestro GM, Seghini P, Zanelli PF, Zanetti A, Savi M, et al. Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population. Dig Liver Dis. 2003;35:571–576
  12. Norris S, Kondeatis E, Collins R, Satsangi J, Clare M, Chapman R, et al. Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism. Gastroenterology. 2001;120:1475–1482
  13. Wiencke K, Spurkland A, Schrumpf E, Boberg KM. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology. 2001;34:625–630
  14. Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, et al. Association of the tumour necrosis factor alpha-308 but not the interleukin 10-627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut. 2001;49:288–294
  15. Bernal W, Moloney M, Underhill J, Donaldson PT. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol. 1999;30:237–241
  16. Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, et al. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. J Hepatol. 2007;46:899–906
  17. Heath SC, Gut IG, Brennan P, McKay JD, Bencko V, Fabianova E, et al. Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet. 2008;16:1413–1429
  18. Sollid LM, Thorsby E. The primary association of celiac disease to a given HLA-DQ alpha/beta heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations. Tissue Antigens. 1990;36:136–137
  19. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980;21:870–877
  20. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005;5:201–214
  21. Robinson J, Waller MJ, Parham P, de Groot N, Bontrop R, Kennedy LJ, et al. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res. 2003;31:311–314
  22. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology. 1991;13:129–133
  23. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978–989
  24. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol. 2003;25:115–121
  25. Tiwari JL, Terasaki PI. The data and statistical analysis. HLA and disease associations. New York: Springer-Verlag; 1985;p. 18–27
  26. Doherty DG, O’Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev. 2000;174:5–20
  27. Hata K, Van Thiel DH, Herberman RB, Whiteside TL. Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease. Hepatology. 1992;15:816–823
  28. Hashimoto E, Lindor KD, Homburger HA, Dickson ER, Czaja AJ, Wiesner RH, et al. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc. 1993;68:1049–1055
  29. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 2004;305:872–874
  30. Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol. 2004;173:4273–4276
  31. Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, et al. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. Ann Neurol. 2009;65:658–666
  32. Ahlenstiel G, Martin MP, Gao X, Carrington M, Rehermann B. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest. 2008;118:1017–1026
  33. Hanvesakul R, Spencer N, Cook M, Gunson B, Hathaway M, Brown R, et al. Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation. Am J Transplant. 2008;8:1931–1941
  34. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature. 2007;450:887–892
  35. Gaudieri S, Kulski JK, Dawkins RL, Gojobori T. Different evolutionary histories in two subgenomic regions of the major histocompatibility complex. Genome Res. 1999;9:541–549
  36. van Bergen J, Thompson A, van der Slik A, Ottenhoff TH, Gussekloo J, Koning F. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol. 2004;173:6719–6726
  37. Kapp JA, Kapp LM, McKenna KC. Gammadelta T cells play an essential role in several forms of tolerance. Immunol Res. 2004;29:93–102
  38. Martins EB, Graham AK, Chapman RW, Fleming KA. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology. 1996;23:988–993
  39. Ponsioen CY, Kuiper H, Ten Kate FJ, de Wit M, van Deventer SJ, Tytgat GN. Immunohistochemical analysis of inflammation in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol. 1999;11:769–774
  40. Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, et al. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms. Hepatology. 2008;47:90–96
  41. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC. Et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev. 1999;167:257–274
  42. Guinan KJ, Cunningham RT, Meenagh A, Dring MM, Middleton D, Gardiner CM. Receptor systems controlling natural killer cell function are genetically stratified in Europe. Genes Immun. 2010;1:67–78
  43. Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur J Gastroenterol Hepatol. 1996;8:685–691
  44. Gaya DR, Russell RK, Nimmo ER, Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases?. Lancet. 2006;367:1271–1284
  45. Escorsell A, Pares A, Rodes J, Solis-Herruzo JA, Miras M, De la Morena E. Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J Hepatol. 1994;21:787–791
  46. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet. 2003;361:865–872

PII: S0168-8278(10)00090-5

doi: 10.1016/j.jhep.2009.11.029

Journal of Hepatology
Volume 52, Issue 5 , Pages 712-717 , May 2010

Article Tools

* Image Usage & Resolution